Pages that link to "Q26738359"
Jump to navigation
Jump to search
The following pages link to Immune checkpoint inhibitors: the new frontier in non-small-cell lung cancer treatment (Q26738359):
Displaying 13 items.
- Epi-drugs in combination with immunotherapy: a new avenue to improve anticancer efficacy (Q38749824) (← links)
- Comprehensive immune transcriptomic analysis in bladder cancer reveals subtype specific immune gene expression patterns of prognostic relevance (Q42378498) (← links)
- Significant benefit of Nivolumab treating PD-L1 positive metastatic pulmonary carcinosarcoma: a case report and literature review (Q47139741) (← links)
- The coexpression of multi-immune inhibitory receptors on T lymphocytes in primary non-small-cell lung cancer (Q47144850) (← links)
- Excellent response to chemotherapy post immunotherapy (Q47259728) (← links)
- Immune checkpoint inhibitors in advanced non-small cell lung cancer (Q47563451) (← links)
- Therapeutic effect of human ghrelin and growth hormone: Attenuation of immunosuppression in septic aged rats (Q48859383) (← links)
- Defining the role of the tumor vasculature in antitumor immunity and immunotherapy (Q49679692) (← links)
- Shikonin induces apoptosis of lung cancer cells via activation of FOXO3a/EGR1/SIRT1 signaling antagonized by p300. (Q51619894) (← links)
- Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation. (Q55316979) (← links)
- Comprehensive analysis of the tumor immune micro-environment in non-small cell lung cancer for efficacy of checkpoint inhibitor (Q57062487) (← links)
- Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer (Q58795373) (← links)
- Onco-omics Approaches and Applications in Clinical Trials for Cancer Patients (Q91238291) (← links)